The effective of diclofenac suppository and bupivacaine on pain relief following laparoscopic herniorrhaphy surgery

A clinical trial to compare the effectiveness of normal saline with diclofenac suppository and bupivacaine on pain relief following laparoscopic herniorrhaphy surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180522039782N2

Enrollment

Registered

2018-10-14

Start date

2018-12-11

Completion date

Unknown

Last updated

2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laparoscopic herniorrhaphy. Unspecified abdominal hernia

Interventions

Intervention 1: Control group: Patients are receiving 500 cc normal saline after surgery. Intervention 2: Intervention group: Patients are receiving 50 mg diclofenac suppository per 8 hours after surg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with ASA class one or two, who are candidate for laparoscopic herniorrhaphy

Exclusion criteria

Exclusion criteria: Allergy to the drugs studied, , , , , , and ; History of hypertension History of uncontrolled diabetes History of cardiovascular diseases History of renal failure History of cirrhosis History of smoking or drug abuse pregnant women

Design outcomes

Primary

Measure	Time frame
Pain relief. Timepoint: 3, 8, 12, 16, 20 and 24 hours after the intervention. Method of measurement: based on the visual analog scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehnood Farazmand

Iran University of Medical Sciences

behnoood@gmail.com+98 21 8842 9230

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 25, 2026